130 related articles for article (PubMed ID: 38922816)
1. Levothyroxine may not adequately prepare hypothyroid women for controlled ovarian hyperstimulation.
Bradbury RA; Byth K; Smith HC
Aust N Z J Obstet Gynaecol; 2024 Jun; ():. PubMed ID: 38922816
[TBL] [Abstract][Full Text] [Related]
2. Prior iodine exposure and impact on thyroid function during controlled ovarian hyperstimulation: A prospective study.
Bradbury RA; Christie-David D; Smith HC; Byth K; Eastman CJ
Aust N Z J Obstet Gynaecol; 2022 Feb; 62(1):133-139. PubMed ID: 34406645
[TBL] [Abstract][Full Text] [Related]
3. Thyroid axis dysregulation during in vitro fertilization in hypothyroid-treated patients.
Busnelli A; Somigliana E; Benaglia L; Sarais V; Ragni G; Fedele L
Thyroid; 2014 Nov; 24(11):1650-5. PubMed ID: 25089619
[TBL] [Abstract][Full Text] [Related]
4. Thyroid function modifications in women undergoing controlled ovarian hyperstimulation for in vitro fertilization: a systematic review and meta-analysis.
Busnelli A; Cirillo F; Levi-Setti PE
Fertil Steril; 2021 Jul; 116(1):218-231. PubMed ID: 33838869
[TBL] [Abstract][Full Text] [Related]
5. Serum and follicular fluid thyroid hormone levels and assisted reproductive technology outcomes.
Cai YY; Lin N; Zhong LP; Duan HJ; Dong YH; Wu Z; Su H
Reprod Biol Endocrinol; 2019 Nov; 17(1):90. PubMed ID: 31699106
[TBL] [Abstract][Full Text] [Related]
6. Impaired outcome of controlled ovarian hyperstimulation in women with thyroid autoimmune disease.
Magri F; Capelli V; Gaiti M; Brambilla E; Montesion L; Rotondi M; Spinillo A; Nappi RE; Chiovato L
Thyroid; 2013 Oct; 23(10):1312-8. PubMed ID: 23556516
[TBL] [Abstract][Full Text] [Related]
7. No role for tri-iodothyronine (T3) testing in the assessment of levothyroxine (T4) over-replacement in hypothyroid patients.
Livingston M; Birch K; Guy M; Kane J; Heald AH
Br J Biomed Sci; 2015; 72(4):160-3. PubMed ID: 26738396
[TBL] [Abstract][Full Text] [Related]
8. Maternal thyroid function in women undergoing controlled ovarian hyperstimulation during in-vitro fertilization and its relation to reproductive outcome.
Abdul Karim AK; Azrai Abu M; Chelliah B; Mohd Razi ZR; Omar MH; Othman H; Man ZC
Minerva Ginecol; 2017 Oct; 69(5):431-437. PubMed ID: 28447444
[TBL] [Abstract][Full Text] [Related]
9. Impact of thyroid-stimulating hormone levels after controlled ovarian hyperstimulation on
Huang N; Chen L; Lian Y; Chi H; Qiao J
Front Endocrinol (Lausanne); 2023; 14():1159991. PubMed ID: 37705573
[TBL] [Abstract][Full Text] [Related]
10. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
11. FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques.
Martins WP; Vieira AD; Figueiredo JB; Nastri CO
Cochrane Database Syst Rev; 2013 Mar; (3):CD010042. PubMed ID: 23543584
[TBL] [Abstract][Full Text] [Related]
12. THE LONG-TERM IMPACT OF CONTROLLED OVARIAN HYPERSTIMULATION ON THYROID FUNCTION.
Busnelli A; Somigliana E; Ferrari S; Filippi F; Vannucchi G; Fugazzola L; Fedele L
Endocr Pract; 2016 Apr; 22(4):389-95. PubMed ID: 26574787
[TBL] [Abstract][Full Text] [Related]
13. Levothyroxine supplementation on assisted reproduction technology (ART) outcomes in women with subtle hypothyroidism: a retrospective study.
Pelliccione F; Lania A; Pizzocaro A; Cafaro L; Negri L; Morenghi E; Betella N; Monari M; Levi-Setti PE
Gynecol Endocrinol; 2018 Dec; 34(12):1053-1058. PubMed ID: 30129807
[TBL] [Abstract][Full Text] [Related]
14. Impact of thyroid autoimmunity in euthyroid women on live birth rate after IUI.
Unuane D; Velkeniers B; Bravenboer B; Drakopoulos P; Tournaye H; Parra J; De Brucker M
Hum Reprod; 2017 Apr; 32(4):915-922. PubMed ID: 28333271
[TBL] [Abstract][Full Text] [Related]
15. Changes in thyroid function during controlled ovarian hyperstimulation (COH) and its impact on assisted reproduction technology (ART) outcomes: a systematic review and meta-analysis.
Li D; Hu S; Meng X; Yu X
J Assist Reprod Genet; 2021 Sep; 38(9):2227-2235. PubMed ID: 33928487
[TBL] [Abstract][Full Text] [Related]
16. Live birth rate after intrauterine insemination is not different between women with lower quartile versus higher quartile normal range thyroid stimulating hormone levels.
Repelaer van Driel-Delprat CC; van Dam EWCM; van de Ven PM; Homsma S; van der Kooij L; Vis E; Peeters RP; Schats R; Lambalk CB
Hum Reprod Open; 2019; 2019(1):hoz002. PubMed ID: 30895267
[TBL] [Abstract][Full Text] [Related]
17. Incidence of elevation of serum thyroid-stimulating hormone during controlled ovarian hyperstimulation for in vitro fertilization.
Benaglia L; Busnelli A; Somigliana E; Leonardi M; Vannucchi G; De Leo S; Fugazzola L; Ragni G; Fedele L
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():53-7. PubMed ID: 24332278
[TBL] [Abstract][Full Text] [Related]
18. Comparison of reproductive outcomes in subclinical hypothyroidism women with high-normal versus low-normal thyroid-stimulating hormone levels after treatment with levothyroxine.
Zhang Y; Liu Y; Li Z; Guan Y
Clin Endocrinol (Oxf); 2023 Mar; 98(3):426-435. PubMed ID: 35902367
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of thyroid autoimmunity and effect of levothyroxine treatment in a cohort of 1064 patients with recurrent pregnancy loss.
Leduc-Robert G; Iews M; Abdelkareem AO; Williams C; Bloomenthal D; Abdelhafez F; Bedaiwy MA
Reprod Biomed Online; 2020 Apr; 40(4):582-592. PubMed ID: 32160949
[TBL] [Abstract][Full Text] [Related]
20. Thyroid-stimulating hormone levels are associated with estradiol levels and impact reproductive outcomes in preconceptionally euthyroid women undergoing their first IVF/ICSI cycles.
Zhang Y; Li J; Liu Y; Li Z; Guan Y
Hormones (Athens); 2024 Mar; ():. PubMed ID: 38443586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
